2489 articles
Must Read Oil Price Forecast: WTI and Brent Rise as U.S.-Iran Deal Hopes Fade
FXEmpire | Tue, 11 Aug 2026 00:07:42 -0400

Oil prices rose to one-week highs on Tuesday as prospects for a U.S.-Iran peace deal weakened following President Trump's demand for compensation from Iran. WTI crude approached $82 and Brent exceeded $90.50, both gaining over 5% on Monday. Supply disruptions through the Strait of Hormuz, where exports dropped from 4.4 million bpd to 3 million bpd week-over-week, are supporting prices alongside delayed refinery restarts.

Show details

JPMorgan Chase will maintain its aggressive hiring pace in Asia Pacific through 2027 after its corporate banking revenue in the region grew by well above 20% this year. The bank is completing a 15% staff increase in 2026 following a 20% expansion in 2025, driven by Asian companies expanding abroad and surging investment in AI, data centers, and supply chains.

Show details

Australian shipbuilder Austal Ltd announced it received a $1.05-1.20 billion offer from Hanwha Defence USA, a unit of South Korea's Hanwha Group, to acquire its U.S. operations. The deal comes as Austal's U.S. business faces significant financial challenges, with expected operating losses of A$175 million for the fiscal year ending June 30.

Show details

President Donald Trump confirmed he spoke with Federal Reserve Chairman Kevin Warsh 'one time, briefly, a few days ago,' denying an earlier report that the two had spoken repeatedly since Warsh became chairman in May 2025. The controversy highlights ongoing concerns about Fed independence as Trump continues to break with presidential precedent by publicly weighing in on interest rate policy.

Show details

Wall Street closed slightly lower on Monday as uncertainty over the Strait of Hormuz reopening pushed oil prices 5% higher and Intel announced a $15 billion stock offering. The Dow fell 0.11%, the S&P 500 dipped 0.06%, and the Nasdaq declined 0.32% as investors awaited key inflation data due later this week.

Show details

The Trump administration extended its Jones Act waiver for another 90 days through mid-November but narrowed its scope to apply only to vessels hauling specific energy resources. The waiver aims to maintain fuel supplies amid disruptions from the U.S.-Israel war with Iran, which has reduced Strait of Hormuz traffic to a trickle and depleted U.S. petroleum reserves to multi-decade lows. The extension comes ahead of midterm elections as inflation concerns persist.

Show details

Oil prices surged approximately 6% after U.S.-Iran negotiations collapsed over the weekend, with Iran demanding reparations as a precondition for reopening the Strait of Hormuz. President Trump rejected Iran's demands and vowed to seek compensation from Iran instead, while maintaining economic pressure through an effective naval blockade that has halted Iranian oil exports.

Show details

Citadel Securities identifies five converging catalysts creating a compelling upside setup for precious metals, marking the firm's first call for structural exposure to gold in 2026. Head of Equity Strategy Scott Rubner highlights dovish Fed repricing, accelerating central bank purchases, net-short positioning, bullish options dynamics, and potential retail resurgence as key drivers for both gold and silver.

Show details

President Trump approved a 90-day extension of the Jones Act waiver with added limitations. The waiver allows foreign-flagged ships to transport cargo between U.S. ports, exempting them from the Jones Act's requirements that ships be U.S.-built, owned, and crewed. The extension aims to reduce gas prices by increasing shipping flexibility and easing transport bottlenecks.

Show details

U.S. stock markets showed minimal movement on Monday, with the S&P 500 holding near Friday's record high while the Dow and Nasdaq slipped slightly. Oil prices surged over 5% to $86 per barrel after stalled negotiations over the Strait of Hormuz reopened geopolitical concerns. The muted trading comes as second-quarter earnings season nears completion with analysts expecting roughly 50% profit growth, the strongest since 2021.

Show details

Prediction markets on Kalshi suggest July's Consumer Price Index will come in below Wall Street economist forecasts ahead of Wednesday's crucial inflation report. Kalshi traders see less than 55% odds that headline CPI exceeds 3.3% year-over-year, while the Dow Jones consensus estimate is 3.4%. The data will be key for Federal Reserve policymakers as they consider interest rate decisions at their September meeting.

Show details

Goldman Sachs' co-head of global banking and markets, Ashok Varadhan, advises investors to remain in the market despite recent concerns about interest rates, oil prices, and economic durability. He cites three positive factors: expectations that the Federal Reserve will not raise rates this year, the potential for AI to drive productivity gains and disinflation, and anticipated oil price declines to below $70 per barrel by late 2026.

Show details

Global commodities traders and financial firms including Trafigura, StoneX, and Macquarie are expanding into Brazil's electricity trading market, capitalizing on rising price volatility and growth opportunities. The expansion comes as several small and mid-sized Brazilian power traders face financial difficulties, creating openings for well-capitalized international players to gain market share.

Show details

The U.S. Senate delayed a vote on major crypto legislation (the Clarity Act) until September, significantly reducing its chances of passage before year-end. The bill faces opposition over weak anti-money laundering rules and ethics provisions, and lawmakers have limited time before November elections dominate their agenda. A September 15 procedural vote will test whether supporters can reach the required 60-vote threshold.

Show details

U.S. markets face a critical week with July CPI data due Wednesday, followed by PPI Thursday and retail sales Friday. The inflation readings are crucial as the Fed weighs policy moves after July's weak jobs report showed payrolls falling by 23,000. Economists expect headline CPI to ease to 3.4% annually and core inflation to moderate to 2.5%, but both remain above the Fed's 2% target.

Show details

U.S.-listed Bitcoin ETFs experienced over $850 million in inflows last week, the highest level since April, following a crypto hack that drained $130 million from Coldcard hardware wallets manufactured by Coinkite. Analysts suggest investors may be shifting to regulated ETFs for greater security after the breach exposed vulnerabilities in cold wallet firmware, though ETFs are not entirely risk-free.

Show details

Wall Street opened cautiously on Monday with the Dow falling 79 points as investors weighed uncertainty over the Strait of Hormuz reopening and awaited key inflation data. Iran indicated progress on Hormuz negotiations but maintained conditions for the U.S., keeping oil prices elevated with WTI at $79 and Brent near $84. Markets are focused on upcoming consumer and producer price reports that could shape Federal Reserve policy expectations.

Show details

Sionna Therapeutics is discontinuing development of its experimental drug SION-719 for cystic fibrosis after it failed to demonstrate meaningful benefit in a mid-stage clinical trial. The drug was being tested as an add-on therapy to Vertex Pharmaceuticals' Trikafta in 15 adults with the genetic disorder, but did not significantly reduce sweat chloride levels, a key efficacy measure.

Show details

The Nasdaq Composite and S&P 500 reached new highs last week following weak jobs data that reduced rate hike expectations. This week's key catalyst is Wednesday's CPI report, expected to show headline inflation at 3.4% year-over-year and core inflation falling to 2.5%, which could further boost stocks if confirmed. Additional market drivers include ongoing corporate earnings and potential US-Iran negotiations over reopening the Strait of Hormuz.

Show details

The UK's medicines regulator has approved Eli Lilly's obesity pill Foundayo for weight management and type 2 diabetes treatment, making the UK the first European country to authorize the medication. This approval expands treatment options for obesity and diabetes patients in Britain and represents a significant regulatory milestone for Lilly in the European market.

Show details